![Utpal Koppikar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Utpal Koppikar
Directeur/Membre du Conseil chez
C4 THERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
Utpal Koppikar is currently an Independent Director at C4 Therapeutics, Inc. since 2022 and Chief Financial Officer at Verily Life Sciences LLC since 2023.
Former positions include Director at Flexion Therapeutics, Inc. in 2021, Vice President-Corporate & Operations Finance at Gilead Sciences, Inc. from 2017 to 2018, and Chief Financial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2018 to 2023.
Education includes graduate studies at Stanford University, undergraduate studies at the University of Maryland, and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Utpal Koppikar
| Sociétés | Poste | Début |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/03/2022 |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Directeur Financier/CFO | 01/04/2023 |
Anciens postes connus de Utpal Koppikar
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 31/03/2023 |
| FLEXION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/11/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2018 |
Formation de Utpal Koppikar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
